# [CL-NA12878N25] Version string: 2.2.0.12/0.3.2:22-06-07/1.0.0/1.0.0/hg19/T
# [CL-NA12878N25] Variants included in this table satisfied at least one of the following criteria:
# [CL-NA12878N25]   - "absent_in_normal": (only applicable when a matched normal sample [MNS] is available) the variant site had non-zero coverage in the MNS and the VAF ratio between the tumor sample and the MNS was >=5.0
# [CL-NA12878N25]   - "ClinVar_classification": the variant falls into one of the following ClinVar classes: Pathogenic, Likely_Pathogenic
# [CL-NA12878N25]   - "CPSR_classification": the variant falls into one of the following CPSR classes (based on refined ACMG criteria): Pathogenic, Likely_Pathogenic
# [CL-NA12878N25] - Required variant class (as determined by the Illumina TSO500 Local App pipeline) - any of:
# [CL-NA12878N25]   - "SOM": the variant wasn't included in any class based on TSO500 LocalApp filtering, it was therefore deemed to be of somatic origin
# [CL-NA12878N25]   - "GL_P": the variant didn't pass the AF-based "germline variant proximity" filter, which looks for (5+) known germline variants with similar AFs located on the same chromosome
# [CL-NA12878N25] - Required variant tier (as determined by the PCGR annotation) - any of:
# [CL-NA12878N25]   - "TIER_1": variant of strong clinical significance (a PCGR-assigned tier)
# [CL-NA12878N25]   - "TIER_2": variant of potential clinical significance (a PCGR-assigned tier)
# [CL-NA12878N25] - Required protein change effect (in any gene transcript overlapping the variant); the format of this inclusion tag is "protein_changes:X", where X is a comma-separated list of variant-associated high-impact coding consequences from the following list:
# [CL-NA12878N25]   - "frameshift_variant"
# [CL-NA12878N25]   - "start_lost"
# [CL-NA12878N25]   - "stop_lost"
# [CL-NA12878N25]   - "stop_gained"
# [CL-NA12878N25]   - "splice_acceptor_variant"
# [CL-NA12878N25]   - "splice_donor_variant"
# [CL-NA12878N25] - In case of PCGR reporting an "intergenic_variant", protein-coding variant effects reported by LocalApp's Nirvana (except for "synonymous_variant", "stop_retained_variant", "start_retained_variant", "transcript_variant", "coding_sequence_variant" or "intron_variant") will be labeled with the following inclusion tag:
# [CL-NA12878N25]   - "intergenic_PCGR_coding_Nirvana"
# [CL-NA12878N25] The "Inclusion_criteria" column lists all the inclusion criteria satisfied by given variant.
# [CL-NA12878N25] Please note that variants present on InPreD's small variant blacklist are recorded in a separate table despite fulfilling at least one of the listed inclusion criteria.
# [CL-NA12878N25] The variants might be flagged by any number of the following custom filters, which point to properties potentially relevant during the quality control process:
# [CL-NA12878N25]   - "normal_origin": the variant was seen only in the MNS (more details below)
# [CL-NA12878N25]   - "germline_population": the variant was seen in at least one of the 1000 genomes/gnomAD (sub-)populations with allelic frequency >=0.001
# [CL-NA12878N25]   - "recurrent_germline": according to the variant InPreD recurrence information, the variant was seen with VAFs >= 0.35 in at least 10 % of investigated normal samples (requires at least 20 callable normal samples)
# [CL-NA12878N25]   - "recurrent_artifact": according to the variant InPreD recurrence information, the variant was seen with VAFs >= [VAF in the processed sample] in at least 10 % of all the investigated tumor samples (based on recurrence table VAF tiers, not exact VAF values; requires at least 20 callable tumor samples)
# [CL-NA12878N25]   - "LOW_TUMOR_DP": the read depth at the variant site in the tumor sample was <20
# [CL-NA12878N25]   - "LOW_TUMOR_VAF": the variant allelic fraction in the tumor sample was <0.02
# [CL-NA12878N25]   - "HIGH_TUMOR_VAF": the variant allelic fraction in the tumor sample was >0.98
# [CL-NA12878N25]   - "LOW_VAF_RATIO": (only applicable when a MNS is available) the ratio between variant allelic fractions in the tumor sample and the MNS was <5.0
# [CL-NA12878N25]   - "HET_VAF_RANGE": the variant allelic fraction in the tumor sample was within the range of 0.5 +/-0.15
# [CL-NA12878N25]   - "NO_NORMAL_COVERAGE": (only applicable when a MNS is available) no coverage data was reported for the variant in the MNS
# [CL-NA12878N25] The "Filters" column lists all the filters failed by given variant.
# [CL-NA12878N25] The "Class_judgement" [CJ] and "Class_judgement_comments" [CJC] columns are pre-filled in order the speed up the manual QC process, but their values should always be checked. A variant can be auto-excluded using the following rules:
# [CL-NA12878N25]   - filters "germline_population", "recurrent_germline", "recurrent_artifact", "LOW_TUMOR_DP" and "LOW_TUMOR_VAF" will serve as exclusion criteria (also, any of these filter values will be copied to the CJC column when encountered);
# [CL-NA12878N25]     - [exception] if a matched control is available and does not contain given variant, encountered "germline_population" and "recurrent_germline" filters will not be used as exclusion criteria; the CJC column will in that case instead contain value "known_germline_variant_absent_in_matched_control";
# [CL-NA12878N25]   - "no_recurrence_data" flag in the CJC column is displayed for variants absent in the input variant recurrence table;
# [CL-NA12878N25]   - if a matched control is available and the "LOW_VAF_RATIO" filter is being applied; the CJC column will include value "variant_in_normal";
# [CL-NA12878N25]   - if a given variant has exactly the coding status combination of "synonymous_variant"and "splice_region_variant" in the primary transcript while no RNA support has been observed for the variant, the CJC column will include value "synonymous_splice_region_variant_with_no_RNA_coverage".
# [CL-NA12878N25] CPSR is run on matched normal samples when possible. Variants not 'found' in the DNA tumor sample (e.g., not fulfilling the required variant class criteria for that sample) will still be present in this table as long as they fulfill any of the following inclusion criteria:
# [CL-NA12878N25]   - "protein_changes:X" (as described above);
# [CL-NA12878N25]   - "intergenic_PCGR_coding_Nirvana" (as described above);
# [CL-NA12878N25]   - "ClinVar_classification" (as described above);
# [CL-NA12878N25]   - "CPSR_classification" (as described above).
# [CL-NA12878N25] The following filters are applicable to the normal-only variants (in addition, the "normal_origin" filter will always be applied):
# [CL-NA12878N25]   - "germline_population" (as described above);
# [CL-NA12878N25]   - "recurrent_germline" (as described above);
# [CL-NA12878N25]   - "recurrent_artifact" (as described above).
# [CL-NA12878N25] In case of normal-only variants, all the listed filters also serve as exclusion criteria. Normal-only variants will always be auto-excluded (they should not contribute to the TMB).
# [CL-NA12878N25] The CJC column comment "synonymous_splice_region_variant_with_no_RNA_coverage" is replaced by comment "synonymous_splice_region_variant_with_unknown_RNA_status" in case of normal-only variants.
# [CL-NA12878N25] The "Coding_transcript_consequences" field has the following format:
# [CL-NA12878N25]   - the transcripts are grouped by sets of associated coding variant consequences (e.g., a group of transcripts with "downstream_gene_variant" consequence and a groups of transcripts with "splice_region_variant,synonymous_variant" consequences);
# [CL-NA12878N25]   - the transcript groups are separated by semicolons and prefixed with a comma-seperated list of the associated consequences;
# [CL-NA12878N25]   - individual transcript records within each group are separated by the pipe symbol ("|") and contain the following elements separated by colons: a source tag ("R" tag for RefSeq, "E" for Ensembl), gene symbol, the "Canonical" tag where applicable, the transcript ID and the cDNA and protein change codes;
# [CL-NA12878N25] Size of the target coding region (in millions ot bases): 1.28
# [CL-NA12878N25] Specified tumor purity (as a fraction between 0 and 1): not specified
# [CL-NA12878N25] The "TNC" tier corresponds to PCGR-assigned tier "NONCODING".
# [CL-NA12878N25] The "TNA" tier is assigned to variants seen only in the MNS (these haven't been annotated by PCGR).
# [CL-NA12878N25] ID of the matched normal DNA sample: NA
# [CL-NA12878N25] ID of the matched tumor RNA sample: NA
# [CL-NA12878N25] "Gene_CN" column format: [High_confidence/non-High_confidence]_[Tumor_CN]/[Adjusted_Tumor_CN]_[Normal_CN]
# [CL-NA12878N25] "Gene_predisposition" column format: [category]_[note]_[associated_tumor_type]
# [CL-NA12878N25]   - category 1: any age, any tumor type
# [CL-NA12878N25]   - category 2: any age, associated tumor type only
# [CL-NA12878N25]   - category 3: age < 30, any tumor type
# [CL-NA12878N25]   - category 4: age < 30, associated tumor type only
# [CL-NA12878N25]   - note a: Renal tumours to be excluded.
# [CL-NA12878N25]   - note b: MUTYH should be included for germline-focussed tumour analysis but reporting and germline follow-up testing should only be performed on detection of two pathogenic variants.
# [CL-NA12878N25]   - note c: Brain tumours to be excluded.
# [CL-NA12878N25] "TSO500_recurrence" column format: [tumor_recurrence_summary]|[normal_recurrence_summary]|[any_sample_recurrence_summary]
# [CL-NA12878N25] The recurrence summary values are written in format "X:A+B+C+D=M/N"
# [CL-NA12878N25]   - X: sample type, one of "T" = tumor, "N" = normal, "A" = any
# [CL-NA12878N25]   - A: number of samples of type X, in which given variant was seen with VAF < 0.01
# [CL-NA12878N25]   - B: number of samples of type X, in which given variant was seen with 0.01 <= VAF < 0.05
# [CL-NA12878N25]   - C: number of samples of type X, in which given variant was seen with 0.05 <= VAF < 0.35
# [CL-NA12878N25]   - D: number of samples of type X, in which given variant was seen with 0.35 <= VAF
# [CL-NA12878N25]   - M: number of samples of type X, in which given variant was seen with any VAF
# [CL-NA12878N25]   - N: number of investigated samples of type X, in which given variant was callable (i.e., the variant site had coverage >= 20)
# [CL-NA12878N25] Information regarding genes interrogated by the FoundationOne Liquid CDx assay (F1LCDx targets):
# [CL-NA12878N25] - retrieved from F1LCDx Technical Specs (document version from July 2021; section "Information Provided as a Professional Service")
# [CL-NA12878N25] - the following optional elements (separated by a semicolon) might be included in the target information string:
# [CL-NA12878N25]   - a gene alias not compatible with PCGR (e.g., "aka[FAM123B]");
# [CL-NA12878N25]   - a list of introns and/or a list of exons (in any order, separated by a comma) investigated at base sensitivity (e.g., "all_exons,introns[7-10]");
# [CL-NA12878N25]   - a list of introns and/or a list of exons (in any order, separated by a comma) investigated at increased sensitivity - jointly prefixed by "IS:" (e.g., "IS:exons[20-29],introns[18-19]");
# [CL-NA12878N25]   - other, special tags, as listed in the source document (e.g., "ncRNA" in case of the TERC gene, or "IS:promoter" in case of the TERT gene).
# [CL-NA12878N25] - E.g., the target information string of BRAF states "all_exons,introns[7-10];IS:exons[11-18]", meaning that introns 7-10 and all exons were investigated at base sensitivity, while exons 11-18 were investigated at increased sensitivity.
Sample_ID	Gene_symbol	Ensembl_transcript_ID	RefSeq_mRNA	Genomic_location	DNA_change	cDNA_change	Exon_number	Protein_change_short	Protein_change	Change_summary	Coding_status	Depth_tumor_DNA	AF_tumor_DNA	Depth_normal_DNA	AF_normal_DNA	Depth_tumor_RNA	AF_tumor_RNA	COSMIC_ID	dbSNP_rs_ID	ClinVar_variation_ID	Global_AF_gnomAD	Global_AF_1KG	NFE_AF_gnomAD	Germline_population_AFs	Mutation_hotspot	TCGA_frequency	ICGC_PCAWG_occurrence	TSO500_recurrence	Putative_driver	Signaling_pathway	Gene_predisposition	Gene_CN	Tier	CPSR_ACMG_class	CPSR_ClinVar_class	TSO500_LocalApp_class	Functional_domain	Drugs	Coding_transcript_consequences	Inclusion_criteria	Filters	F1LCDx_targets	IGV_QC	Run_QC	Class_judgement	Class_judgement_comments	Reporting_judgement	Reporting_judgement_comments
CL-NA12878N25	CDKN2A	ENST00000498124	NM_001195132	9:21975017	C>T	NA	NA	NA	NA	NA	x:noncoding_variant	892	0.999	NA	NA	NA	NA	COSV58720858	rs3814960	873184	NA	0.4878	NA	GLOBAL_AF_1KG:0.4878000|AFR_AF_1KG:0.1793000|AMR_AF_1KG:0.4424000|EAS_AF_1KG:0.6657000|EUR_AF_1KG:0.6243000|SAS_AF_1KG:0.6135000	NA	NA	NA	T:5+3+18+387=413/461|N:2+0+0+91=93/104|A:7+3+18+478=506/565	NA	CC	NA	[non-HC]_2.106/2.212_NA	TIER_2	Likely_Benign	Benign	GL_DB	NA	NA	upstream_gene_variant:R:CDKN2A:XM_005251343.1|R:CDKN2A:NM_058197.4|E:CDKN2A:ENST00000579122.1|E:CDKN2A:ENST00000578845.2|E:CDKN2A:ENST00000498124.1|E:CDKN2A:ENST00000479692.2|E:CDKN2A:ENST00000497750.1;5_prime_UTR_variant:R:CDKN2A:NM_001195132.1|R:CDKN2A:Canonical:NM_000077.4|E:CDKN2A:ENST00000304494.5|R:CDKN2A:XM_005251341.1|E:CDKN2A:ENST00000446177.1	tier	recurrent_germline|HIGH_TUMOR_VAF|germline_population	IS:all_exons	.	.	exclude	germline_population,recurrent_germline	.	.
CL-NA12878N25	ASXL1	ENST00000375687	NM_015338	20:31022441	AG>A	c.1934del	exon13	G645fs	Gly645ValfsTer58	c.1934del:exon13:G645fs:Gly645ValfsTer58	frameshift_variant	905	0.021	NA	NA	NA	NA	NA	rs750318549	NA	0.0002859	NA	0.0003429	NA	NA	Stomach_Adenocarcinoma:_1.1%_(5/437)|Colon_Adenocarcinoma:_0.8%_(3/399)|Thymoma:_0.8%_(1/123)|Uterine_Corpus_Endometrial_Carcinoma:_0.8%_(4/530)|Cervical_Squamous_Cell_Carcinoma_and_Endocervical_Adenocarcinoma:_0.7%_(2/289)|Esophageal_Carcinoma:_0.5%_(1/184)	LIRI-JP/Primary/1/250/0.004	T:70+369+2+0=441/463|N:6+95+0+0=101/103|A:76+464+2+0=542/566	NA	NA	NA	[non-HC]_1.92/1.84_NA	TIER_3	VUS	NA	BL	NA	NA	frameshift_variant:R:ASXL1:Canonical:NP_056153.2:p.(Gly645ValfsTer58)|E:ASXL1:Canonical:ENSP00000364839.4:p.(Gly645ValfsTer58)|E:ASXL1:ENSP00000305119.5:p.(Gly640ValfsTer58);downstream_gene_variant:E:ASXL1:ENST00000553345.1	protein_changes:frameshift_variant	recurrent_artifact	all_exons	.	.	exclude	recurrent_artifact,variant_in_more_than_10%_of_tumor_samples_(15.12%)_with_VAF_under_0.01,BL_class	.	.
CL-NA12878N25	BCR	ENST00000305877	NM_004327	22:23653975	T>TCCGG	c.3275_3278dup	exon19	V1094fs	Val1094ArgfsTer17	c.3275_3278dup:exon19:V1094fs:Val1094ArgfsTer17	frameshift_variant	953	0.163	NA	NA	NA	NA	NA	rs372013175	1206149	8e-06	NA	0.0000000	NA	NA	NA	NA	T:5+88+308+0=401/461|N:1+24+63+0=88/104|A:6+112+371+0=489/565	NA	NA	NA	[non-HC]_1.996/1.992_NA	TIER_3	VUS	VUS	BL	RhoGAP_domain	Ponatinib|Nilotinib_Hydrochloride_Monohydrate|Dasatinib|Ponatinib_Hydrochloride|Nilotinib|Bosutinib|Radotinib|Imatinib	frameshift_variant:E:BCR:Canonical:ENSP00000303507.8:p.(Val1094ArgfsTer17)|E:BCR:ENSP00000352535.3:p.(Val1050ArgfsTer17)|R:BCR:Canonical:NP_004318.3:p.(Val1094ArgfsTer17)|R:BCR:NP_067585.2:p.(Val1050ArgfsTer17)	protein_changes:frameshift_variant	recurrent_artifact	introns[8,13-14]	.	.	exclude	recurrent_artifact,BL_class	.	.
CL-NA12878N25	KMT2C	ENST00000262189	NM_170606	7:151874147	CT>C	c.8390del	exon38	K2797fs	Lys2797ArgfsTer26	c.8390del:exon38:K2797fs:Lys2797ArgfsTer26	frameshift_variant	392	0.066	NA	NA	NA	NA	NA	rs747256476	NA	0.002251	NA	0.0015780	GLOBAL_AF_GNOMAD:0.0022510|AMR_AF_GNOMAD:0.0025070|EAS_AF_GNOMAD:0.0017430|NFE_AF_GNOMAD:0.0015780|OTH_AF_GNOMAD:0.0020890|SAS_AF_GNOMAD:0.0074670	NA	Thymoma:_0.8%_(1/123)|Cervical_Squamous_Cell_Carcinoma_and_Endocervical_Adenocarcinoma:_0.3%_(1/289)|Stomach_Adenocarcinoma:_0.2%_(1/437)|Uterine_Corpus_Endometrial_Carcinoma:_0.2%_(1/530)	NA	T:16+403+27+3=449/463|N:2+88+13+0=103/104|A:18+491+40+3=552/567	NA	NA	NA	[non-HC]_2.024/2.048_NA	TIER_3	NA	NA	BL	NA	NA	frameshift_variant:E:KMT2C:ENSP00000353218.3:p.(Lys303ArgfsTer26)|R:KMT2C:XP_005250087.1:p.(Lys2798ArgfsTer26)|R:KMT2C:XP_005250086.1:p.(Lys2798ArgfsTer26)|R:KMT2C:XP_005250085.1:p.(Lys2814ArgfsTer26)|R:KMT2C:XP_005250082.1:p.(Lys2814ArgfsTer26)|R:KMT2C:XP_005250084.1:p.(Lys2814ArgfsTer26)|R:KMT2C:XP_005250088.1:p.(Lys2814ArgfsTer26)|E:KMT2C:ENSP00000262189.6:p.(Lys2797ArgfsTer26)|R:KMT2C:XP_005250083.1:p.(Lys2813ArgfsTer26)|R:KMT2C:Canonical:NP_733751.2:p.(Lys2797ArgfsTer26)|E:KMT2C:Canonical:ENSP00000347325.2:p.(Lys2797ArgfsTer26);downstream_gene_variant:E:KMT2C:ENST00000558665.1	protein_changes:frameshift_variant	germline_population	NA	.	.	exclude	germline_population,BL_class	.	.
CL-NA12878N25	TET1	ENST00000373644	NM_030625	10:70405539	ATA>GTG	c.3053_3055delinsGTG	exon4	N1018_K1019delinsSE	Asn1018_Lys1019delinsSerGlu	c.3053_3055delinsGTG:exon4:N1018_K1019delinsSE:Asn1018_Lys1019delinsSerGlu	missense_variant	407	0.486	NA	NA	NA	NA	NA	rs71483917	NA	NA	NA	NA	NA	NA	NA	NA	T:3+1+6+27=37/463|N:0+0+0+10=10/104|A:3+1+6+37=47/567	NA	NA	NA	[non-HC]_1.802/1.604_NA	TIER_3	NA	NA	SOM	NA	NA	missense_variant:R:TET1:Canonical:NP_085128.2:p.(Asn1018_Lys1019delinsSerGlu)|E:TET1:Canonical:ENSP00000362748.4:p.(Asn1018_Lys1019delinsSerGlu)	class	HET_VAF_RANGE	NA	.	.	include	.	.	.
CL-NA12878N25	ALK	ENST00000389048	NM_004304	2:29455199	A>T	c.2603T>A	exon15	L868Q	Leu868Gln	c.2603T>A:exon15:L868Q:Leu868Gln	missense_variant	912	0.486	NA	NA	NA	NA	NA	rs55941323	335700	8e-06	2e-04	0.0000176	EUR_AF_1KG:0.0010000	NA	NA	NA	T:8+0+0+0=8/462|N:1+0+0+1=2/104|A:9+0+0+1=10/566	NA	RTKRAS	NA	[HC]_2.13/2.26_NA	TIER_3	VUS	VUS	GL_P	Glycine_rich_protein	Alectinib|Entrectinib|Ceritinib|Lorlatinib|Brigatinib|Ensartinib|Crizotinib	missense_variant:E:ALK:Canonical:ENSP00000373700.3:p.(Leu868Gln)|R:ALK:Canonical:NP_004295.2:p.(Leu868Gln)	class	HET_VAF_RANGE|germline_population	all_exons;IS:exons[20-29],introns[18-19]	.	.	exclude	germline_population	.	.
CL-NA12878N25	BARD1	ENST00000260947	NM_000465	2:215632255	CA>TG	c.1518_1519inv	exon6	V507M	Val507Met	c.1518_1519inv:exon6:V507M:Val507Met	missense_variant	532	0.476	NA	NA	NA	NA	NA	rs386654966	215471	NA	NA	NA	NA	NA	NA	NA	T:47+3+31+246=327/463|N:0+0+0+73=73/104|A:47+3+31+319=400/567	NA	NA	NA	[non-HC]_2.126/2.252_NA	TIER_3	Likely_Benign	Likely_Benign	GL_P	Ankyrin_repeat	NA	missense_variant:R:BARD1:XP_005246785.1:p.(Val410Met)|R:BARD1:XP_005246784.1:p.(Val488Met)|E:BARD1:Canonical:ENSP00000260947.4:p.(Val507Met)|R:BARD1:Canonical:NP_000456.2:p.(Val507Met)|R:BARD1:NP_001269472.1:p.(Val488Met)|R:BARD1:NP_000456.2:p.(Val507Met)|E:BARD1:ENSP00000406752.2:p.(Val363Met)	class	recurrent_germline|HET_VAF_RANGE	all_exons	.	.	exclude	recurrent_germline,variant_in_more_than_10%_of_tumor_samples_(10.15%)_with_VAF_under_0.01	.	.
CL-NA12878N25	AKT1	ENST00000554581	NA	14:105239791	C>A	c.828+1G>T	NA	NA	NA	c.828+1G>T:NA:NA:NA	splice_donor_variant	940	0.014	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	T:16+0+0+0=16/463|N:1+1+0+0=2/104|A:17+1+0+0=18/567	NA	PI3K	NA	[non-HC]_2.068/2.136_NA	TIER_3	Likely_Pathogenic	NA	SOM	NA	Ipatasertib|Capivasertib	splice_donor_variant:R:AKT1:XM_005267402.1|R:AKT1:NM_005163.2|E:AKT1:ENST00000554581.1|R:AKT1:XM_005267401.1|E:AKT1:ENST00000407796.2|R:AKT1:NM_001014431.1|R:AKT1:Canonical:NM_001014432.1|E:AKT1:Canonical:ENST00000349310.3|E:AKT1:ENST00000402615.2|E:AKT1:ENST00000555528.1|E:AKT1:ENST00000554192.1|E:AKT1:ENST00000544168.1|E:AKT1:ENST00000554848.1;upstream_gene_variant:E:AKT1:ENST00000555458.1;downstream_gene_variant:E:AKT1:ENST00000555380.1|E:AKT1:ENST00000555926.1	class|protein_changes:splice_donor_variant|CPSR_classification	LOW_TUMOR_VAF	all_exons;IS:exons[3]	.	.	exclude	LOW_TUMOR_VAF	.	.
CL-NA12878N25	KMT2C	ENST00000262189	NM_170606	7:151962134	G>T	c.1173C>A	exon8	C391X	Cys391Ter	c.1173C>A:exon8:C391X:Cys391Ter	stop_gained	1177	0.096	NA	NA	NA	NA	COSV51275177	rs146238849	1205926	0.002894	NA	0.0021730	GLOBAL_AF_GNOMAD:0.0028940|AFR_AF_GNOMAD:0.0052530|AMR_AF_GNOMAD:0.0021360|ASJ_AF_GNOMAD:0.0017770|FIN_AF_GNOMAD:0.0020150|NFE_AF_GNOMAD:0.0021730|OTH_AF_GNOMAD:0.0031280|SAS_AF_GNOMAD:0.0081030	NA	NA	NA	T:24+101+158+0=283/463|N:1+19+46+0=66/104|A:25+120+204+0=349/567	NA	NA	NA	[non-HC]_2.024/2.048_NA	TIER_3	NA	NA	BL	PHD-finger	NA	stop_gained:R:KMT2C:XP_005250087.1:p.(Cys392Ter)|R:KMT2C:XP_005250086.1:p.(Cys392Ter)|R:KMT2C:XP_005250085.1:p.(Cys392Ter)|R:KMT2C:XP_005250082.1:p.(Cys392Ter)|R:KMT2C:XP_005250084.1:p.(Cys392Ter)|R:KMT2C:XP_005250088.1:p.(Cys392Ter)|E:KMT2C:ENSP00000262189.6:p.(Cys391Ter)|R:KMT2C:XP_005250083.1:p.(Cys391Ter)|R:KMT2C:Canonical:NP_733751.2:p.(Cys391Ter)|E:KMT2C:Canonical:ENSP00000347325.2:p.(Cys391Ter)	protein_changes:stop_gained	recurrent_artifact|germline_population	NA	.	.	exclude	germline_population,recurrent_artifact,BL_class	.	.
CL-NA12878N25	PRKDC	ENST00000314191	NM_006904	8:48805816	A>AG	c.3729dup	exonNA	R1244fs	Arg1244ProfsTer41	c.3729dup:exonNA:R1244fs:Arg1244ProfsTer41	frameshift_variant,splice_polypyrimidine_tract_variant,splice_region_variant,intron_variant	681	0.971	NA	NA	NA	NA	NA	rs11411516	NA	1	NA	1.0000000	GLOBAL_AF_GNOMAD:1.0000000|AFR_AF_1KG:1.0000000|AFR_AF_GNOMAD:0.9999000|AMR_AF_1KG:1.0000000|AMR_AF_GNOMAD:0.9999000|ASJ_AF_GNOMAD:1.0000000|EAS_AF_1KG:1.0000000|EAS_AF_GNOMAD:1.0000000|EUR_AF_1KG:1.0000000|FIN_AF_GNOMAD:1.0000000|NFE_AF_GNOMAD:1.0000000|OTH_AF_GNOMAD:1.0000000|SAS_AF_1KG:1.0000000|SAS_AF_GNOMAD:1.0000000	NA	NA	NA	T:0+0+0+463=463/463|N:0+0+0+104=104/104|A:0+0+0+567=567/567	NA	NA	NA	[non-HC]_1.93/1.86_NA	TIER_4	NA	NA	BL	NA	NA	frameshift_variant,splice_region_variant:E:PRKDC:Canonical:ENSP00000313420.2:p.(Arg1244ProfsTer41)|E:PRKDC:ENSP00000345182.3:p.(Arg1244ProfsTer41);frameshift_variant:R:PRKDC:NM_001081640.1:c.3729dup(p.(Ter1244=))|R:PRKDC:Canonical:NM_006904.6:c.3729dup(p.(Ter1244=))	protein_changes:frameshift_variant	recurrent_germline|germline_population	NA	.	.	exclude	germline_population,recurrent_germline,BL_class	.	.
CL-NA12878N25	KMT2B	ENST00000222270	NA	19:36214632	A>AG	c.3059dup	exonNA	R1021fs	Arg1021ProfsTer14	c.3059dup:exonNA:R1021fs:Arg1021ProfsTer14	frameshift_variant,splice_region_variant	494	1	NA	NA	NA	NA	NA	rs11373774	NA	1	NA	1.0000000	GLOBAL_AF_GNOMAD:1.0000000|AFR_AF_1KG:1.0000000|AFR_AF_GNOMAD:1.0000000|AMR_AF_1KG:1.0000000|AMR_AF_GNOMAD:1.0000000|ASJ_AF_GNOMAD:1.0000000|EAS_AF_1KG:1.0000000|EAS_AF_GNOMAD:1.0000000|EUR_AF_1KG:1.0000000|FIN_AF_GNOMAD:0.9999000|NFE_AF_GNOMAD:1.0000000|OTH_AF_GNOMAD:1.0000000|SAS_AF_1KG:1.0000000|SAS_AF_GNOMAD:1.0000000	NA	NA	NA	T:0+0+0+463=463/463|N:0+0+0+104=104/104|A:0+0+0+567=567/567	NA	NA	NA	[non-HC]_2.026/2.052_NA	TIER_4	NA	NA	BL	NA	NA	downstream_gene_variant:E:KMT2B:ENST00000341701.1;splice_acceptor_variant:E:KMT2B:ENSP00000398837.1:p.(Arg1021ProfsTer14);frameshift_variant,splice_region_variant:E:KMT2B:Canonical:ENSP00000222270.6:p.(Arg1021ProfsTer14)|R:KMT2B:NP_055542.1:p.(Arg1021ProfsTer14)|R:KMT2B:Canonical:NP_055542.1:p.(Arg1021ProfsTer14)|R:KMT2B:XP_005259503.1:p.(Arg262ProfsTer14)	protein_changes:splice_acceptor_variant,frameshift_variant	recurrent_germline|HIGH_TUMOR_VAF|germline_population	NA	.	.	exclude	germline_population,recurrent_germline,BL_class	.	.
CL-NA12878N25	TFE3	ENST00000315869	NM_001282142|NM_006521	X:48887977	C>T	c.1420G>A	exon10	A474T	Ala474Thr	c.1420G>A:exon10:A474T:Ala474Thr	missense_variant	907	0.016	NA	NA	NA	NA	COSV59946172	rs782018183	NA	1.1e-05	NA	0.0000249	NA	NA	NA	NA	T:78+1+0+0=79/463|N:9+1+0+0=10/104|A:87+2+0+0=89/567	NA	NA	NA	[non-HC]_2.24/2.48_NA	TIER_4	VUS	NA	SOM	Domain_of_unknown_function_(DUF3371)	NA	missense_variant:R:TFE3:XP_005272701.1:p.(Ala369Thr)|R:TFE3:Canonical:NP_006512.2:p.(Ala474Thr)|R:TFE3:NP_001269071.1:p.(Ala369Thr)|R:TFE3:NP_006512.2:p.(Ala474Thr)|E:TFE3:Canonical:ENSP00000314129.7:p.(Ala474Thr)	class	LOW_TUMOR_VAF	NA	.	.	exclude	LOW_TUMOR_VAF,variant_in_more_than_10%_of_tumor_samples_(16.85%)_with_VAF_under_0.01	.	.
CL-NA12878N25	RAD50	ENST00000265335	NA	5:131925483	G>C	c.1406G>C	exon9	G469A	Gly469Ala	c.1406G>C:exon9:G469A:Gly469Ala	missense_variant	317	0.498	NA	NA	NA	NA	NA	rs55653181	216618	4e-06	2e-04	0.0000089	EUR_AF_1KG:0.0010000	NA	NA	NA	T:8+0+0+0=8/463|N:0+0+0+1=1/104|A:8+0+0+1=9/567	NA	NA	NA	[non-HC]_1.812/1.624_NA	TIER_4	VUS	VUS	GL_P	NA	NA	missense_variant:E:RAD50:ENSP00000368100.3:p.(Gly330Ala)|R:RAD50:Canonical:NP_005723.2:p.(Gly469Ala)|E:RAD50:Canonical:ENSP00000265335.6:p.(Gly469Ala)|E:RAD50:ENSP00000400049.1:p.(Gly469Ala);upstream_gene_variant:E:RAD50:ENST00000434288.1	class	HET_VAF_RANGE|germline_population	NA	.	.	exclude	germline_population	.	.
CL-NA12878N25	TCF7L2	ENST00000543371	NA	10:114925491	C>T	c.1569C>T	exon14	P523P	Pro523=	c.1569C>T:exon14:P523P:Pro523=	synonymous_variant	779	0.48	NA	NA	NA	NA	COSV53340782	rs76249005	NA	8e-06	2e-04	0.0000088	EUR_AF_1KG:0.0010000	NA	NA	NA	T:122+2+0+0=124/463|N:9+0+0+1=10/104|A:131+2+0+1=134/567	NA	WNT	NA	[non-HC]_1.882/1.764_NA	TNC	Likely_Benign	NA	SOM	NA	NA	downstream_gene_variant:R:TCF7L2:XM_005270091.1|E:TCF7L2:ENST00000352065.5|E:TCF7L2:ENST00000369389.1|E:TCF7L2:ENST00000277945.7;3_prime_UTR_variant:R:TCF7L2:XM_005270100.1|R:TCF7L2:XM_005270096.1|R:TCF7L2:XM_005270094.1|R:TCF7L2:XM_005270093.1|R:TCF7L2:XM_005270104.1|R:TCF7L2:XM_005270102.1|R:TCF7L2:XM_005270103.1|R:TCF7L2:XM_005270095.1|R:TCF7L2:XM_005270101.1|E:TCF7L2:ENST00000355717.4|E:TCF7L2:ENST00000538897.1|R:TCF7L2:NM_001198529.1|R:TCF7L2:NM_001198531.1|R:TCF7L2:NM_001146283.1|R:TCF7L2:NM_001198525.1|R:TCF7L2:NM_001198527.1|R:TCF7L2:NM_001198528.1|R:TCF7L2:NM_001146284.1|R:TCF7L2:NM_001198530.1|R:TCF7L2:NM_001146286.1|R:TCF7L2:XM_005270106.1|R:TCF7L2:XM_005270105.1|E:TCF7L2:ENST00000369386.1	class	HET_VAF_RANGE|germline_population	NA	.	.	exclude	germline_population,variant_in_more_than_10%_of_tumor_samples_(26.35%)_with_VAF_under_0.01	.	.
CL-NA12878N25	FANCI	ENST00000310775	NM_001376911|NM_001376910|NM_001113378	15:89817440	G>A	c.1017G>A	exon12	K339K	Lys339=	c.1017G>A:exon12:K339K:Lys339=	synonymous_variant	340	0.482	NA	NA	NA	NA	NA	rs72762644	886651	1.73e-05	2e-04	0.0000393	EUR_AF_1KG:0.0010000	NA	NA	NA	T:28+0+0+0=28/463|N:1+0+0+1=2/104|A:29+0+0+1=30/567	NA	NA	NA	[non-HC]_2.116/2.232_NA	TNC	Likely_Benign	VUS	GL_P	FANCI_helical_domain_1	NA	NA	class	HET_VAF_RANGE|germline_population	NA	.	.	exclude	germline_population	.	.
CL-NA12878N25	NCOR1	ENST00000268712	NM_006311	17:16062134	G>C	c.672C>G	exon6	S224S	Ser224=	c.672C>G:exon6:S224S:Ser224=	synonymous_variant	749	0.479	NA	NA	NA	NA	NA	rs72835314	NA	1.59e-05	2e-04	0.0000264	EUR_AF_1KG:0.0010000	NA	NA	NA	T:4+0+0+0=4/463|N:1+0+0+1=2/104|A:5+0+0+1=6/567	NA	NOTCH	NA	[non-HC]_2.008/2.016_NA	TNC	NA	NA	GL_P	NA	NA	NA	class	HET_VAF_RANGE|germline_population	NA	.	.	exclude	germline_population	.	.
CL-NA12878N25	PREX2	ENST00000288368	NM_024870	8:68993013	AT>GC	c.1818_1819delinsGC	exon17	GL606-607GL	GlyLeu606=	c.1818_1819delinsGC:exon17:GL606-607GL:GlyLeu606=	synonymous_variant	286	0.448	NA	NA	NA	NA	NA	rs368406603	NA	NA	NA	NA	NA	NA	NA	NA	T:4+2+39+327=372/462|N:1+0+1+90=92/104|A:5+2+40+417=464/566	NA	NA	NA	[non-HC]_2.072/2.144_NA	TNC	NA	NA	GL_P	NA	NA	NA	class	recurrent_germline|HET_VAF_RANGE	NA	.	.	exclude	recurrent_germline	.	.
CL-NA12878N25	KIF5B	ENST00000302418	NM_004521	10:32298093	G>C	NA	NA	NA	NA	NA	x:noncoding_variant	524	0.477	NA	NA	NA	NA	NA	rs72775184	NA	NA	2e-04	NA	EUR_AF_1KG:0.0010000	NA	NA	NA	T:11+0+0+0=11/463|N:0+0+0+1=1/104|A:11+0+0+1=12/567	NA	NA	NA	[non-HC]_2.066/2.132_NA	TNC	NA	NA	SOM	NA	Selpercatinib	3_prime_UTR_variant:E:KIF5B:Canonical:ENST00000302418.4|R:KIF5B:Canonical:NM_004521.2	class	HET_VAF_RANGE|germline_population	NA	.	.	exclude	germline_population	.	.
CL-NA12878N25	PTEN	ENST00000371953	NM_000314	10:89677086	A>G	NA	NA	NA	NA	NA	x:noncoding_variant	447	0.486	NA	NA	NA	NA	NA	rs55692819	NA	NA	4e-04	NA	AMR_AF_1KG:0.0014000|EUR_AF_1KG:0.0010000	NA	NA	NA	T:6+0+0+1=7/463|N:1+0+0+1=2/104|A:7+0+0+2=9/567	NA	PI3K	NA	[HC]_1.908/1.816_NA	TNC	Likely_Benign	NA	SOM	NA	NA	NA	class	HET_VAF_RANGE|germline_population	IS:all_exons	.	.	exclude	germline_population	.	.
CL-NA12878N25	TERT	ENST00000310581	NM_198253	5:1295243	G>A	NA	NA	NA	NA	NA	x:noncoding_variant	450	0.509	NA	NA	NA	NA	NA	rs35550267	NA	NA	NA	NA	NA	NA	NA	NA	T:0+8+0+0=8/348|N:2+0+0+1=3/74|A:2+8+0+1=11/422	NA	NA	NA	NA	TNC	Likely_Benign	NA	SOM	NA	NA	upstream_gene_variant:E:TERT:Canonical:ENST00000310581.5|R:TERT:NM_001193376.1|R:TERT:Canonical:NM_198253.2|E:TERT:ENST00000296820.5|E:TERT:ENST00000334602.6|E:TERT:ENST00000508104.2	class	HET_VAF_RANGE	IS:promoter	.	.	include	.	.	.
CL-NA12878N25	ETV1	ENST00000430479	NM_001370556|NM_004956	7:13988434	C>T	NA	NA	NA	NA	NA	x:noncoding_variant	507	0.483	NA	NA	NA	NA	NA	rs73068195	NA	NA	2e-04	NA	EUR_AF_1KG:0.0010000	NA	NA	NA	T:56+1+0+0=57/463|N:3+0+0+1=4/104|A:59+1+0+1=61/567	NA	NA	NA	[non-HC]_1.956/1.912_NA	TNC	NA	NA	GL_P	NA	NA	NA	class	HET_VAF_RANGE|germline_population	NA	.	.	exclude	germline_population,variant_in_more_than_10%_of_tumor_samples_(12.1%)_with_VAF_under_0.01	.	.
CL-NA12878N25	ETV1	ENST00000430479	NM_001370556|NM_004956	7:14017007	CC>TG	NA	NA	NA	NA	NA	x:noncoding_variant	256	1	NA	NA	NA	NA	NA	rs71523042	NA	NA	NA	NA	NA	NA	NA	NA	T:3+1+35+329=368/463|N:0+0+1+81=82/104|A:3+1+36+410=450/567	NA	NA	NA	[non-HC]_1.956/1.912_NA	TNC	NA	NA	GL_P	NA	NA	NA	class	recurrent_germline|HIGH_TUMOR_VAF	NA	.	.	exclude	recurrent_germline	.	.
CL-NA12878N25	ETV1	ENST00000430479	NM_001370556|NM_004956	7:14021333	TT>GC	NA	NA	NA	NA	NA	x:noncoding_variant	220	1	NA	NA	NA	NA	NA	rs71523043	NA	NA	NA	NA	NA	NA	NA	NA	T:1+1+23+342=367/462|N:0+0+0+82=82/104|A:1+1+23+424=449/566	NA	NA	NA	[non-HC]_1.956/1.912_NA	TNC	NA	NA	GL_P	NA	NA	NA	class	recurrent_germline|HIGH_TUMOR_VAF	NA	.	.	exclude	recurrent_germline	.	.
CL-NA12878N25	ETV6	ENST00000396373	NM_001987	12:12014191	G>T	NA	NA	NA	NA	NA	x:noncoding_variant	961	0.515	NA	NA	NA	NA	NA	rs56239741	NA	NA	4e-04	NA	EUR_AF_1KG:0.0020000	NA	NA	NA	T:46+1+0+0=47/463|N:5+0+0+1=6/104|A:51+1+0+1=53/567	NA	NA	NA	[non-HC]_2.028/2.056_NA	TNC	Likely_Benign	NA	GL_P	NA	NA	NA	class	HET_VAF_RANGE|germline_population	IS:introns[5-6],all_exons	.	.	exclude	germline_population	.	.
CL-NA12878N25	FGF4	ENST00000168712	NM_002007	11:69592814	AGA>GGG	NA	NA	NA	NA	NA	x:noncoding_variant	191	0.518	NA	NA	NA	NA	NA	rs386754669	NA	NA	NA	NA	NA	NA	NA	NA	T:6+2+18+59=85/460|N:0+0+2+17=19/104|A:6+2+20+76=104/564	NA	NA	NA	[HC]_2.104/2.208_NA	TNC	NA	NA	GL_P	NA	NA	upstream_gene_variant:E:FGF4:Canonical:ENST00000168712.1|R:FGF4:Canonical:NM_002007.2|R:FGF4:XM_005273847.1	class	recurrent_germline|HET_VAF_RANGE	all_exons	.	.	exclude	recurrent_germline	.	.
CL-NA12878N25	NA	NA	NA	14:38053817	T>C	NA	NA	NA	NA	NA	x:noncoding_variant	756	0.508	NA	NA	NA	NA	NA	rs72674245	NA	NA	NA	NA	NA	NA	NA	NA	T:13+0+0+0=13/462|N:3+0+0+1=4/104|A:16+0+0+1=17/566	NA	NA	NA	NA	TNC	NA	NA	GL_P	NA	NA	downstream_gene_variant:R:FOXA1:Canonical:NM_004496.3	class|intergenic_PCGR_coding_Nirvana	HET_VAF_RANGE	NA	.	.	include	.	.	.
CL-NA12878N25	NPM1	ENST00000296930	NM_002520	5:170833472	AAT>A	NA	NA	NA	NA	NA	x:noncoding_variant	556	0.493	NA	NA	NA	NA	NA	rs1017868545	NA	NA	NA	NA	NA	NA	NA	NA	T:1+0+0+0=1/462|N:0+0+0+1=1/104|A:1+0+0+1=2/566	NA	NA	NA	[non-HC]_1.952/1.904_NA	TNC	NA	NA	GL_P	NA	Ceritinib|Crizotinib	3_prime_UTR_variant:R:NPM1:XM_005265920.1|R:NPM1:NM_001037738.2|E:NPM1:ENST00000393820.2	class	HET_VAF_RANGE	all_exons;IS:exons[4-6,8,10]	.	.	include	.	.	.
CL-NA12878N25	NTRK1	ENST00000524377	NM_002529	1:156845774	C>T	NA	NA	NA	NA	NA	x:noncoding_variant	851	0.513	NA	NA	NA	NA	NA	rs72698669	NA	NA	2e-04	NA	EUR_AF_1KG:0.0010000	NA	NA	NA	T:81+1+0+1=83/463|N:11+0+0+1=12/104|A:92+1+0+2=95/567	NA	RTKRAS	NA	[non-HC]_2.024/2.048_NA	TNC	Likely_Benign	NA	GL_P	NA	Regorafenib|Regorafenib_Hydrate|Entrectinib|Larotrectinib|Larotrectinib_Sulfate	NA	class	HET_VAF_RANGE|germline_population	all_exons;IS:introns[8-11],exons[14-15]	.	.	exclude	germline_population,variant_in_more_than_10%_of_tumor_samples_(17.49%)_with_VAF_under_0.01	.	.
CL-NA12878N25	PPARG	ENST00000287820	NM_015869	3:12409711	CTC>TGT	NA	NA	NA	NA	NA	x:noncoding_variant	5	1	NA	NA	NA	NA	NA	rs796734365	NA	NA	NA	NA	NA	NA	NA	NA	T:0+0+0+91=91/91|N:0+0+0+14=14/14|A:0+0+0+105=105/105	NA	NA	NA	[non-HC]_1.968/1.936_NA	TNC	NA	NA	GL_P	NA	NA	NA	class	recurrent_artifact|LOW_TUMOR_DP|HIGH_TUMOR_VAF	all_exons	.	.	exclude	LOW_TUMOR_DP,recurrent_artifact,too_few_(14<20)_callable_normals	.	.
CL-NA12878N25	ROS1	ENST00000368508	NM_002944	6:117657902	T>G	NA	NA	NA	NA	NA	x:noncoding_variant	323	0.498	NA	NA	NA	NA	NA	rs72963572	NA	NA	2e-04	NA	EUR_AF_1KG:0.0010000	NA	NA	NA	T:2+0+0+0=2/462|N:1+0+0+1=2/104|A:3+0+0+1=4/566	NA	RTKRAS	NA	[non-HC]_2.112/2.224_NA	TNC	Likely_Benign	NA	GL_P	NA	Entrectinib	NA	class	HET_VAF_RANGE|germline_population	all_exons;IS:introns[31-35],exons[31,36-38,40]	.	.	exclude	germline_population	.	.
CL-NA12878N25	ERCC2	ENST00000391945	NM_000400	19:45854767	CG>C	NA	NA	NA	NA	NA	x:noncoding_variant	824	0.465	NA	NA	NA	NA	COSV67267814	rs3916890	1209384	NA	0.0178	NA	GLOBAL_AF_1KG:0.0178000|AFR_AF_1KG:0.0219000|AMR_AF_1KG:0.0130000|EUR_AF_1KG:0.0249000|SAS_AF_1KG:0.0266000	NA	NA	NA	T:1+0+1+45=47/463|N:0+0+0+10=10/104|A:1+0+1+55=57/567	NA	NA	NA	[HC]_2.2/2.4_NA	TNC	Likely_Benign	Likely_Benign	GL_DB	NA	NA	downstream_gene_variant:E:KLC3:ENST00000589373.1|E:KLC3:ENST00000589837.1|E:KLC3:ENST00000590063.1|R:ERCC2:XM_005258641.1|R:ERCC2:XM_005258639.1|R:ERCC2:XM_005258640.1|E:ERCC2:ENST00000391944.3|E:ERCC2:ENST00000391941.2;3_prime_UTR_variant:R:KLC3:Canonical:NM_177417.2|E:KLC3:ENST00000391946.2|E:KLC3:ENST00000585434.1|E:KLC3:Canonical:ENST00000470402.1|R:KLC3:XM_005258538.1|R:KLC3:XM_005258539.1|E:ERCC2:Canonical:ENST00000391945.4|R:ERCC2:Canonical:NM_000400.3;frameshift_variant:R:KLC3:XP_005258593.1:p.(Val646Ter)|R:KLC3:XP_005258594.1:p.(Val645Ter)	protein_changes:frameshift_variant	HET_VAF_RANGE|germline_population	NA	.	.	exclude	germline_population	.	.
CL-NA12878N25	NA	NA	NA	14:38054085	T>G	NA	NA	NA	NA	NA	x:noncoding_variant	473	0.488	NA	NA	NA	NA	NA	rs10149161	NA	NA	NA	NA	AFR_AF_1KG:0.9032000|AMR_AF_1KG:0.7464000|EAS_AF_1KG:0.7927000|EUR_AF_1KG:0.6690000|SAS_AF_1KG:0.6462000	NA	NA	NA	T:2+5+98+311=416/457|N:1+0+16+75=92/101|A:3+5+114+386=508/558	NA	NA	NA	NA	TNC	NA	NA	GL_DB	NA	NA	downstream_gene_variant:R:FOXA1:Canonical:NM_004496.3	intergenic_PCGR_coding_Nirvana	recurrent_germline|HET_VAF_RANGE|germline_population	NA	.	.	exclude	germline_population,recurrent_germline	.	.
CL-NA12878N25	LRRC14	ENST00000292524	NM_014665	8:145738767	CG>C	NA	NA	NA	NA	NA	x:noncoding_variant	1018	0.984	NA	NA	NA	NA	COSV52878080	NA	1327943	NA	NA	NA	NA	NA	NA	NA	T:0+0+0+463=463/463|N:0+0+0+104=104/104|A:0+0+0+567=567/567	NA	NA	NA	NA	TNC	Benign	Benign	BL	NA	NA	downstream_gene_variant:R:MFSD3:XM_005272311.1|R:MFSD3:Canonical:NM_138431.2|E:MFSD3:Canonical:ENST00000301327.4|R:MFSD3:NM_138431.1|E:RECQL4:ENST00000532846.2|E:RECQL4:ENST00000524998.1;frameshift_variant,splice_donor_variant:E:RECQL4:Canonical:ENSP00000475456.1:p.(Arg766GlyfsTer77);upstream_gene_variant:R:LRRC14:XM_005272361.1|R:LRRC14:NM_001272036.1|R:LRRC14:Canonical:NM_014665.3|R:LRRC14:XM_005272358.1|R:LRRC14:XM_005272360.1|R:LRRC14:XM_005272359.1|E:LRRC14:ENST00000527730.1|E:LRRC14:ENST00000529022.1|E:LRRC14:Canonical:ENST00000292524.1|E:LRRC14:ENST00000530854.1	protein_changes:splice_donor_variant,frameshift_variant	recurrent_germline|HIGH_TUMOR_VAF	NA	.	.	exclude	recurrent_germline,BL_class	.	.
CL-NA12878N25	MAP3K14	ENST00000344686	NM_003954	17:43364293	C>CG	NA	NA	NA	NA	NA	x:noncoding_variant	918	0.965	NA	NA	NA	NA	NA	rs56405343	NA	1	NA	1.0000000	GLOBAL_AF_GNOMAD:1.0000000|AFR_AF_1KG:1.0000000|AFR_AF_GNOMAD:0.9999000|AMR_AF_1KG:1.0000000|AMR_AF_GNOMAD:1.0000000|ASJ_AF_GNOMAD:1.0000000|EAS_AF_1KG:1.0000000|EAS_AF_GNOMAD:0.9999000|EUR_AF_1KG:1.0000000|FIN_AF_GNOMAD:1.0000000|NFE_AF_GNOMAD:1.0000000|OTH_AF_GNOMAD:1.0000000|SAS_AF_1KG:1.0000000|SAS_AF_GNOMAD:1.0000000	NA	NA	NA	T:0+0+0+463=463/463|N:0+0+0+104=104/104|A:0+0+0+567=567/567	NA	NA	NA	[non-HC]_1.918/1.836_NA	TNC	NA	NA	BL	NA	NA	frameshift_variant,splice_region_variant:R:MAP3K14:NP_003945.2:p.(Ala219GlyfsTer42);frameshift_variant:R:MAP3K14:Canonical:NP_003945.2:p.(Arg219ProfsTer730)	protein_changes:frameshift_variant	recurrent_germline|germline_population	NA	.	.	exclude	germline_population,recurrent_germline,BL_class	.	.
CL-NA12878N25	SETBP1	ENST00000282030	NA	18:42456670	C>CTCTT	NA	NA	NA	NA	NA	x:noncoding_variant	654	0.442	NA	NA	NA	NA	COSV56311994	rs3085861	326725	0.5217	0.4938	0.5498000	GLOBAL_AF_1KG:0.4938000|GLOBAL_AF_GNOMAD:0.5217000|AFR_AF_1KG:0.5098000|AFR_AF_GNOMAD:0.5353000|AMR_AF_1KG:0.4539000|AMR_AF_GNOMAD:0.4765000|ASJ_AF_GNOMAD:0.5903000|EAS_AF_1KG:0.4762000|EAS_AF_GNOMAD:0.4998000|EUR_AF_1KG:0.5616000|FIN_AF_GNOMAD:0.5951000|NFE_AF_GNOMAD:0.5498000|OTH_AF_GNOMAD:0.5141000|SAS_AF_1KG:0.4489000|SAS_AF_GNOMAD:0.4231000	NA	NA	NA	T:3+5+37+347=392/463|N:1+0+0+91=92/104|A:4+5+37+438=484/567	NA	NA	NA	[non-HC]_1.86/1.72_NA	TNC	Benign	Benign	BL	NA	NA	frameshift_variant:E:SETBP1:ENSP00000390687.3:p.(Thr228SerfsTer8)|R:SETBP1:NP_001123582.1:p.(Thr228SerfsTer8)	protein_changes:frameshift_variant	recurrent_germline|HET_VAF_RANGE|germline_population	NA	.	.	exclude	germline_population,recurrent_germline,BL_class	.	.
